Recovery Solutions Capital was founded to assist investors in three special categories:
When a firm liquidates a fund, there are three options to take in regards to class action filing:
There is not an industry standard practice, and each firm must determine what is best for their specific needs.
Recovery Solutions Capital walks through those options with investors, and if the decision to sell the recovery rights is chosen, will review the fund and put together a straight-forward bid to buy the recovery rights.
Filing claims in Opt-In Cases does not guarantee a recovery. Therefore, investors can choose to do the following:
Determining the appropriate action in an Opt-In Case is particularly subjective, and it is integral for investors to understand the ins and outs to decide upon the proper course of action.
Recovery Solutions Capital assists investors to review the nuances involved in this marketplace, and if the decision to sell the recovery rights is chosen, will review the claim and put together a straight-forward bid to buy the recovery rights.
The Global Securities Litigation marketplace is ever-evolving, with both case and market particulars changing week to week. Whether investors have chosen to file in-house, use a third-party filer, or their Custodian Bank (or a mix of all three), Recovery Solutions Capital partners with the investor to determine what is best for their firm. This assistance can be a one-time review (such as an internal audit or a Vendor Due Diligence), a more complex vendor comparison (such as a RFP or RFI), or a continuous support throughout the year.
In January 2016, Merck & Co said it would pay $830 million to settle a …
In June 2016, BP Plc agreed to pay $175 million to shareholders who brought a …
In August 2016, Pfizer Inc. reached a $486 million settlement regarding a litigation case accusing …